Multiple Sclerosis Treatment

ZINCARE

M. Chomba

Multiple Sclerosis Year in Review 2024

UF Health Norman Fixel Institute for Neurological Diseases

T. Rempe

COVID-19 & Multiple Sclerosis: Can Immunosuppressive Therapy Decreas…

Gavin Giovannoni

Aberrant Iron Deposition in the Progressive MS Spinal Cord Relates t…

Marco Pisa

Multiple Sclerosis for the Non-Neurologist

Providence Swedish

J. D. Bowen

Symptomatic Management in Multiple Sclerosis

ZINCARE

A. Simpson

The Role of B Cells in Progressive MS and the Long-term Effects of B…

The France Foundation

J. Berger

NMOSD and MOGAD Clinical Trials

Siegel Rare Neuroimmune Association

M. Levy

The Connection Between Viruses and Other Factors Contributing to the…

The France Foundation

M. Levy

Neural effects of fatigue on cognition in relapsing MS detected by m…

2023 Conference Coverage

A. Memon

Breaking Down Common But Complicated Questions in MS: Updates on Bio…

Women Neurologists Group (WNG)

E. M. Schorr

Strategies to Promote Myelin Repair

OHSU

L. Wooliscroft

ECTRIMS 2024 Insights: Role of Diet, Vitamins and in MS

Anneke Van Der Walt

Effectiveness of Tixagevimab/Cilgavimab (Evusheld) in AntiCD20-Treat…

Dominika Stastna

MS Relapse Redefined: Distinguishing True Relapses from Pseudoexacer…

Stephen Krieger

Highlights on Multiple Sclerosis: Topographical Model of MS and JC V…

2023 Conference Coverage

S. Krieger

Neurological Reserve in Multiple Sclerosis: Concepts, Metrics, and P…

University at Buffalo Neurology Department

R. H.B. Benedict

ECTRIMS 2024 Insights: Increased Brain Age Is Associated With Clinic…

Lonneke Bos

Navigating Neurogenic Bladder and Sexual Dysfunction

Diagnosis and Management of Neurogenic Bladder and Sexual Dysfunction Video Series

T. Kaplan

ECTRIMS 2024 Insights: Clinical Spectrum of MOG Antibody-Associated …

Kazuo Fujihara